ON
← Back to feed
Theranos whistleblower Tyler Shultz warns that the AI boom is ‘a great opportunity to go deceive people’
United States💼 Business

Theranos whistleblower Tyler Shultz warns that the AI boom is ‘a great opportunity to go deceive people’

The release of the documentary 'You Can See Everything,' which chronicles Elizabeth Holmes' final weeks before imprisonment, has reignited public interest in the Theranos scandal. Tyler Shultz, a former employee and key whistleblower who helped expose the company's fraudulent blood-testing devices, argues that the current AI boom presents a similar risk of deception. He contends that the difficulty of conducting technical due diligence on artificial intelligence allows unproven startups to secure massive valuations based on hype rather than functional products. Shultz warns that investors are forgetting the lessons learned from Theranos, where lack of transparency regarding the technology enabled significant financial fraud. He emphasizes that the ease of securing large early-stage investments today mirrors the dynamics that allowed Holmes to scale her deceptive practices.

Elizabeth Holmes has criticized the widely circulated photograph taken during her trial, prompting a response from the photographer who captured the image. The picture shows the former Theranos chief executive holding a small vial of blood while seated at the defense table. This reaction comes amid renewed public attention following the release of the documentary "You Can See Everything," directed by Nathan Fielder and Lance Oppenheim. The film documents Holmes' final weeks before she surrendered to begin serving a prison sentence exceeding eleven years. It has become one of the highest-grossing documentaries in history. Tyler Shultz, a former employee and key whistleblower who helped expose the company's inaccurate blood testing devices, commented on the ongoing media fascination with Holmes. Shultz stated that the primary reason for current discussion is Holmes' desire to maintain public visibility. He noted that her ability to elicit pity persists even among those aware of her criminal conduct. Shultz warned that the current artificial intelligence boom presents a significant risk for deception. He argued that investors often lack the tools to distinguish between genuine technological breakthroughs and superficial applications built on existing platforms like ChatGPT. Shultz highlighted the dangers of insufficient due diligence in the tech sector. He recalled that Theranos raised approximately $100 million in funding, a sum he described as scaling a simple model of exchanging cash for brief meetings. The company achieved a peak valuation near $10 billion despite its proprietary technology failing to function properly. Theranos outsourced the majority of its tests to third-party equipment. Funding largely came from individual investors, including the DeVos and Walton families, rather than traditional venture capital firms. The company withheld scientific evidence from investors, citing trade secret protections, which deterred many Silicon Valley firms. George Shultz, Tyler Shultz's grandfather and former U.S. Secretary of State and Treasury, served as an investor and board member. He emphasized that providing such large sums of capital grants individuals immense power. In the documentary, Holmes appears alongside her partner, hotel heir Billy Evans, developing a new diagnostics venture called Haemanthus. The couple describes the project as a successor to Theranos, and reports indicate it has secured roughly $20 million in funding. The film explores why Holmes invited filmmakers to document her life with her two young children prior to incarceration. While the documentary avoids labeling her solely as a manipulator or victim, it highlights her capacity to influence perception. Critics point out that the film minimizes specific harms, such as delivering faulty medical results to patients through Walgreens locations.

How this report was made. Objective News wrote this report from 2 source articles, using AI-assisted synthesis under our methodology. It is our own text, not a copy of any single outlet. Read our methodology.

Responsible editor: Matej BašaSpotted an error? Report it

2 reports

The Washington Times logoThe Washington TimesParty-alignedCenter
Photographer of famous Elizabeth Holmes photo reacts to her disliking it

A photographer has responded to recent comments by former Theranos CEO Elizabeth Holmes regarding a well-known image of her holding a blood vial. The article notes that Holmes expressed dislike for this specific photograph, which became iconic during the rise of her biotechnology company. The photographer’s reaction addresses these criticisms directly, though the provided text does not detail the specific content of his response or the broader context of their professional relationship.

Bias read (Center): The subject is corporate history and personal opinion rather than public policy, resulting in minimal political charge and neutral framing.

TechCrunch logoTechCrunchIndependentCenter
Theranos whistleblower Tyler Shultz warns that the AI boom is ‘a great opportunity to go deceive people’

The release of the documentary 'You Can See Everything,' which chronicles Elizabeth Holmes' final weeks before imprisonment, has reignited public interest in the Theranos scandal. Tyler Shultz, a former employee and key whistleblower who helped expose the company's fraudulent blood-testing devices, argues that the current AI boom presents a similar risk of deception. He contends that the difficulty of conducting technical due diligence on artificial intelligence allows unproven startups to secure massive valuations based on hype rather than functional products. Shultz warns that investors are forgetting the lessons learned from Theranos, where lack of transparency regarding the technology enabled significant financial fraud. He emphasizes that the ease of securing large early-stage investments today mirrors the dynamics that allowed Holmes to scale her deceptive practices.

Bias read (Center): The article neutrally reports on a whistleblower's opinion regarding investment risks in the AI sector, using balanced language and focusing on economic mechanisms rather than partisan politics.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories